top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

NKTR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.07%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $99,202.16

Nektar Therapeutics Insider Trading History Chart

Nektar Therapeutics Share Price & Price History

^$1.38

▼ -0.04 (-2.82%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

The "Smart Money" Is Ready for May 1st Are You?

From Stansberry Research | Ad

Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company.

One Former Wall St. Trader Explains Why…

Nektar Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/20/2024	Howard W Robin	CEO	Sell	20,033	$0.68	$13,622.44	879,889
2/20/2024	Jonathan Zalevsky	Insider	Sell	9,014	$0.68	$6,129.52	265,025
11/17/2023	Howard W Robin	CEO	Sell	19,877	$0.49	$9,739.73	899,922
11/17/2023	Jonathan Zalevsky	Insider	Sell	9,646	$0.49	$4,726.54	274,039
9/18/2023	Myriam Curet	Director	Sell	4,359	$0.69	$3,007.71	27,418
8/16/2023	Howard W Robin	CEO	Sell	19,998	$0.78	$15,598.44	919,799
8/16/2023	Jonathan Zalevsky	Insider	Sell	9,703	$0.78	$7,568.34	283,685
6/14/2023	Roy A Whitfield	Director	Sell	30,000	$0.57	$17,100.00	216,250
5/16/2023	Howard W Robin	CEO	Sell	20,361	$0.72	$14,659.92	939,797
5/16/2023	Jonathan Zalevsky	Insider	Sell	9,791	$0.72	$7,049.52	293,388
2/16/2023	Howard W Robin	CEO	Sell	19,635	$3.00	$58,905.00	960,158
2/16/2023	Jillian B. Thomsen	CFO	Sell	10,267	$3.00	$30,801.00	313,497
2/16/2023	Jonathan Zalevsky	Insider	Sell	10,484	$3.00	$31,452.00	303,179
11/16/2022	Howard W Robin	CEO	Sell	38,014	$3.57	$135,709.98	979,793
11/16/2022	Jillian B. Thomsen	CFO	Sell	11,095	$3.57	$39,609.15	323,764
11/16/2022	Jonathan Zalevsky	Insider	Sell	13,460	$3.57	$48,052.20	313,663
9/23/2022	Myriam Curet	Director	Sell	4,198	$3.16	$13,265.68	31,777
9/13/2022	Karin Eastham	Director	Sell	21,267	$3.61	$76,773.87	13,033
8/18/2022	Jonathan Zalevsky	Insider	Sell	73,716	$4.65	$342,779.40	327,123
8/16/2022	Howard W Robin	CEO	Sell	13,759	$4.76	$65,492.84	1,017,807
8/16/2022	Jillian B. Thomsen	CAO	Sell	2,006	$4.76	$9,548.56	334,859
8/16/2022	Jonathan Zalevsky	Insider	Sell	10,560	$4.76	$50,265.60	400,839
8/16/2022	Mark Andrew Wilson	SVP	Sell	3,189	$4.76	$15,179.64	281,188
5/16/2022	Gil M. Labrucherie	CFO	Sell	17,448	$3.95	$68,919.60	312,905
5/16/2022	Howard W Robin	CEO	Sell	36,529	$3.95	$144,289.55	620,941
5/16/2022	Jillian B. Thomsen	CAO	Sell	5,841	$3.95	$23,071.95	170,427
5/16/2022	Jonathan Zalevsky	Insider	Sell	21,673	$3.95	$85,608.35	276,399
5/16/2022	Mark Andrew Wilson	SVP	Sell	3,136	$3.95	$12,387.20	117,939
2/16/2022	Gil M. Labrucherie	CFO	Sell	7,579	$10.95	$82,990.05
2/16/2022	Howard W Robin	CEO	Sell	12,480	$10.95	$136,656.00
2/16/2022	Jillian B. Thomsen	CAO	Sell	2,363	$10.95	$25,874.85
2/16/2022	John Northcott	SVP	Sell	4,852	$10.95	$53,129.40
2/16/2022	Jonathan Zalevsky	Insider	Sell	10,912	$10.95	$119,486.40
11/18/2021	Gil M. Labrucherie	CFO	Sell	3,000	$12.69	$38,070.00
11/16/2021	Gil M. Labrucherie	CFO	Sell	21,149	$13.16	$278,320.84
9/22/2021	Myriam Curet	Director	Sell	3,665	$17.78	$65,163.70
9/8/2021	Robert Chess	Director	Sell	8,000	$16.00	$128,000.00	282,273
8/16/2021	Gil M. Labrucherie	CFO	Sell	7,867	$13.83	$108,800.61
8/16/2021	Howard W. Robin	CEO	Sell	11,515	$13.83	$159,252.45	424,123
8/16/2021	Jillian B. Thomsen	CAO	Sell	13,339	$13.83	$184,478.37
8/16/2021	Jonathan Zalevsky	Insider	Sell	7,662	$13.83	$105,965.46
8/16/2021	Mark Andrew Wilson	SVP	Sell	1,910	$13.83	$26,415.30	200,915
7/21/2021	Robert Chess	Director	Sell	3,524	$16.81	$59,238.44
5/17/2021	Gil M. Labrucherie	CFO	Sell	7,898	$18.30	$144,533.40
5/17/2021	Howard W Robin	CEO	Sell	11,560	$18.30	$211,548.00	435,638
5/17/2021	Jillian B. Thomsen	CAO	Sell	13,391	$18.30	$245,055.30
5/17/2021	Jonathan Zalevsky	Insider	Sell	31,111	$18.30	$569,331.30	235,065
5/17/2021	Mark Andrew Wilson	SVP	Sell	1,917	$18.30	$35,081.10	207,107
5/12/2021	Robert Chess	Director	Sell	8,000	$19.34	$154,720.00	288,573

Biden replacement revealed?

From Paradigm Press | Ad

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report

SEC Filings (Institutional Ownership Changes) for Nektar Therapeutics (NASDAQ:NKTR)

75.88% of Nektar Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nektar Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/24/2024	Assenagon Asset Management S.A.	1,687,300	$1.58M	0.0%	-31.6%	0.919%
2/16/2024	GSA Capital Partners LLP	5,255,790	$2.97M	0.2%	+185.5%	2.755%
2/16/2024	Public Employees Retirement System of Ohio	274,924	$0.16M	0.0%	-11.4%	0.144%
2/9/2024	Primecap Management Co. CA	7,001,747	$3.96M	0.0%	-2.7%	3.670%
2/7/2024	Monaco Asset Management SAM	5,973,387	$3.38M	1.0%	+24.2%	3.131%
2/5/2024	Russell Investments Group Ltd.	112,769	$64K	0.0%	-28.9%	0.059%
2/2/2024	Marquette Asset Management LLC	186,163	$0.11M	0.0%	+25.5%	0.098%
2/2/2024	Acuitas Investments LLC	911,204	$0.52M	0.3%	+26.3%	0.478%
1/30/2024	Mackenzie Financial Corp	75,034	$42K	0.0%	N/A	0.039%
1/17/2024	Assenagon Asset Management S.A.	2,466,267	$1.39M	0.0%	-13.0%	1.293%
1/12/2024	SG Americas Securities LLC	101,687	$57K	0.0%	+30.6%	0.053%
12/6/2023	Citigroup Inc.	77,978	$46K	0.0%	+1,993.9%	0.041%
11/15/2023	RA Capital Management L.P.	18,700,000	$11.14M	0.2%	N/A	9.802%
11/15/2023	GSA Capital Partners LLP	1,841,078	$1.10M	0.1%	+931.5%	0.965%
11/14/2023	Lynx1 Capital Management LP	1,766,815	$1.05M	0.7%	N/A	0.926%
11/14/2023	Primecap Management Co. CA	7,197,983	$4.29M	0.0%	-11.7%	3.773%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	491,975	$0.29M	0.0%	-22.5%	0.258%
11/13/2023	Acadian Asset Management LLC	7,626,388	$4.54M	0.0%	+73.5%	3.998%
11/7/2023	Monaco Asset Management SAM	4,809,601	$2.87M	0.8%	-48.1%	2.530%
11/7/2023	CM Management LLC	800,000	$0.48M	0.5%	+6.7%	0.421%
11/7/2023	Barclays PLC	229,841	$0.14M	0.0%	+300.9%	0.121%
11/6/2023	Assenagon Asset Management S.A.	2,835,463	$1.69M	0.0%	+36.3%	1.491%
10/30/2023	First Citizens Bank & Trust Co.	51,311	$31K	0.0%	-47.7%	0.027%
10/24/2023	Bank of New York Mellon Corp	88,259	$53K	0.0%	-30.1%	0.046%
10/20/2023	Harbor Capital Advisors Inc.	49,769	$30K	0.0%	-39.9%	0.026%
10/13/2023	SG Americas Securities LLC	77,858	$46K	0.0%	-27.4%	0.041%
9/21/2023	Barclays PLC	57,332	$33K	0.0%	-62.5%	0.030%
8/14/2023	Deep Track Capital LP	17,973,464	$10.34M	0.5%	+931.0%	9.454%
8/8/2023	Monaco Asset Management SAM	9,260,717	$5.33M	1.5%	N/A	4.894%
8/7/2023	Principal Financial Group Inc.	53,034	$31K	0.0%	-95.4%	0.028%
8/7/2023	Acadian Asset Management LLC	4,396,020	$2.53M	0.0%	+597.5%	2.323%
8/4/2023	CM Management LLC	750,000	$0.43M	0.4%	+87.5%	0.396%
7/31/2023	Moloney Securities Asset Management LLC	355,105	$0.20M	0.0%	N/A	0.188%
7/31/2023	Inspire Investing LLC	551,556	$0.32M	0.0%	+40.1%	0.291%
7/28/2023	Marquette Asset Management LLC	148,378	$85K	0.0%	N/A	0.078%
7/25/2023	Assenagon Asset Management S.A.	2,080,518	$1.20M	0.0%	+213.6%	1.099%
7/11/2023	Harbor Capital Advisors Inc.	82,798	$48K	0.0%	N/A	0.044%
7/10/2023	SG Americas Securities LLC	107,236	$62K	0.0%	-39.4%	0.057%
5/11/2023	Acadian Asset Management LLC	630,249	$0.44M	0.0%	+2,606.6%	0.333%
5/10/2023	Pictet Asset Management SA	3,720,679	$2.62M	0.0%	+221.9%	1.966%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	448,227	$0.32M	0.0%	+177.8%	0.237%
5/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	99,010	$70K	0.0%	-50.8%	0.052%
5/8/2023	CM Management LLC	400,000	$0.28M	0.3%	+220.0%	0.211%
5/8/2023	Federated Hermes Inc.	1,900,784	$1.34M	0.0%	+2.6%	1.004%
5/1/2023	Texas Permanent School Fund Corp	168,558	$0.12M	0.0%	+34.1%	0.089%
4/28/2023	SG Americas Securities LLC	176,969	$0.12M	0.0%	+297.8%	0.094%
4/27/2023	New York State Teachers Retirement System	253,113	$0.18M	0.0%	-5.0%	0.134%
4/24/2023	Inspire Investing LLC	393,749	$0.28M	0.0%	+273.2%	0.208%
4/18/2023	Assenagon Asset Management S.A.	663,500	$0.47M	0.0%	+121.7%	0.351%
3/28/2023	Acrisure Capital Management LLC	72,131	$0.16M	0.2%	N/A	0.038%
2/15/2023	Tang Capital Management LLC	164,190	$0.37M	0.1%	-61.8%	0.087%
2/15/2023	Braidwell LP	620,280	$1.40M	0.0%	N/A	0.330%
2/14/2023	Alpine Global Management LLC	55,062	$0.12M	0.0%	N/A	0.029%
2/13/2023	Edgestream Partners L.P.	608,851	$1.38M	0.2%	-41.9%	0.324%
2/13/2023	ExodusPoint Capital Management LP	492,500	$1.11M	0.0%	+1,486.2%	0.262%
2/13/2023	GSA Capital Partners LLP	645,035	$1.46M	0.2%	+988.0%	0.343%
2/10/2023	New York Life Investment Management LLC	105,240	$0.24M	0.0%	+12.7%	0.056%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	161,327	$0.37M	0.0%	+1,406.5%	0.086%
2/10/2023	HRT Financial LP	420,455	$0.95M	0.0%	+80.6%	0.224%
2/10/2023	Blair William & Co. IL	40,786	$92K	0.0%	-74.1%	0.022%
2/9/2023	CM Management LLC	125,000	$0.28M	0.3%	+150.0%	0.067%
2/9/2023	Principal Financial Group Inc.	1,177,797	$2.66M	0.0%	+0.3%	0.627%
2/8/2023	Cambridge Investment Research Advisors Inc.	132,232	$0.30M	0.0%	N/A	0.070%
2/8/2023	Swiss National Bank	452,500	$1.02M	0.0%	+2.4%	0.241%
2/8/2023	Russell Investments Group Ltd.	163,091	$0.37M	0.0%	+96.3%	0.087%
2/7/2023	Texas Permanent School Fund	125,741	$0.28M	0.0%	-6.3%	0.067%
2/7/2023	State Board of Administration of Florida Retirement System	67,437	$0.15M	0.0%	-8.3%	0.036%
2/7/2023	Commonwealth Equity Services LLC	17,455	$39K	0.0%	-15.9%	0.009%
2/6/2023	Ieq Capital LLC	11,594	$26K	0.0%	-83.0%	0.006%
2/3/2023	Birchview Capital LP	118,000	$0.27M	0.2%	-7.8%	0.063%
2/2/2023	SG Americas Securities LLC	44,491	$0.10M	0.0%	+110.1%	0.024%
2/2/2023	ProShare Advisors LLC	44,375	$100K	0.0%	+8.6%	0.024%
2/1/2023	Bank of Montreal Can	34,334	$78K	0.0%	-32.1%	0.018%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	33,757	$76K	0.0%	+35.5%	0.018%
1/31/2023	Everence Capital Management Inc.	29,760	$67K	0.0%	-37.6%	0.016%
1/26/2023	Comerica Bank	110,531	$0.28M	0.0%	-21.9%	0.059%
1/26/2023	Inspire Investing LLC	105,499	$0.24M	0.0%	+62.9%	0.056%
1/23/2023	Allspring Global Investments Holdings LLC	188,869	$0.43M	0.0%	+42.5%	0.100%
1/18/2023	Maryland State Retirement & Pension System	77,479	$0.18M	0.0%	N/A	0.041%
1/12/2023	Hennion & Walsh Asset Management Inc.	88,904	$0.20M	0.0%	-60.1%	0.047%
1/10/2023	Coldstream Capital Management Inc.	14,455	$33K	0.0%	N/A	0.008%
1/9/2023	Yousif Capital Management LLC	118,925	$0.27M	0.0%	-21.0%	0.063%
11/16/2022	Verus Capital Partners LLC	41,008	$0.13M	0.0%	N/A	0.022%
11/15/2022	Algert Global LLC	476,412	$1.53M	0.1%	+10.0%	0.253%
11/15/2022	Primecap Management Co. CA	16,422,443	$52.55M	0.1%	-0.8%	8.737%
11/15/2022	Edgestream Partners L.P.	1,047,636	$3.35M	0.3%	-1.8%	0.557%
11/15/2022	Federated Hermes Inc.	837,065	$2.68M	0.0%	+675.2%	0.445%
11/15/2022	Bayesian Capital Management LP	30,300	$97K	0.0%	-63.1%	0.016%
11/15/2022	Bellevue Group AG	14,800	$47K	0.0%	-48.6%	0.008%
11/15/2022	Caxton Associates LP	50,531	$0.16M	0.0%	-55.6%	0.027%
11/14/2022	Macquarie Group Ltd.	258,941	$0.84M	0.0%	-1.5%	0.138%
11/14/2022	Tudor Investment Corp Et Al	267,063	$0.86M	0.0%	-44.8%	0.142%
11/14/2022	Cubist Systematic Strategies LLC	204,913	$0.66M	0.0%	-21.9%	0.109%
11/14/2022	PDT Partners LLC	307,953	$0.99M	0.1%	-63.0%	0.164%
11/14/2022	Ergoteles LLC	19,191	$61K	0.0%	N/A	0.010%
11/14/2022	Metropolitan Life Insurance Co NY	7,890	$25K	0.0%	-28.5%	0.004%
11/14/2022	Hsbc Holdings PLC	80,667	$0.26M	0.0%	+88.2%	0.043%
11/14/2022	Pictet Asset Management SA	860,218	$2.75M	0.0%	+149.9%	0.458%
11/14/2022	Cipher Capital LP	14,512	$46K	0.0%	N/A	0.008%
11/14/2022	Hennion & Walsh Asset Management Inc.	223,047	$0.71M	0.0%	-4.6%	0.119%

Data available starting January 2016

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. The company is developing rezpegaldesleukin, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; and NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer squamous cell carcinoma and colorectal cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.

Today's Range

Now: $1.38

$1.37

$1.42

50 Day Range

MA: $1.00

$0.66

$1.67

52 Week Range

Now: $1.38

$0.41

$1.75

Volume

958,001 shs

Average Volume

2,164,889 shs

Market Capitalization

$253.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of Nektar Therapeutics?: Nektar Therapeutics' top insider investors include:
Howard W Robin (CEO)
Jonathan Zalevsky (Insider)
Jillian B Thomsen (CAO)
Jillian B Thomsen (CFO)
Gil M Labrucherie (CFO)
Mark Andrew Wilson (SVP)
Roy A Whitfield (Director)
Myriam Curet (Director)
Karin Eastham (Director)
Learn More about top insider investors at Nektar Therapeutics.
Who are the major institutional investors of Nektar Therapeutics?: Nektar Therapeutics' top institutional shareholders include:
Assenagon Asset Management S.A. — 0.92%
Learn More about top institutional investors of Nektar Therapeutics stock.
Which major investors are selling Nektar Therapeutics stock?: Within the previous quarter, NKTR stock was sold by these institutional investors:
Assenagon Asset Management S.A.
In the previous year, company insiders that have sold Nektar Therapeutics company stock include:
Howard W Robin (CEO)
Jonathan Zalevsky (Insider)
Jillian B Thomsen (CAO)
Jillian B Thomsen (CFO)
Learn More investors selling Nektar Therapeutics stock.